Final Destination: Bloodlines is proving to be a major hit at the U.S. box office, raking in an impressive $4.8 million on Memorial Day Monday. This performance marks the biggest second Monday haul in franchise history, and just a minimal 4.8% drop from the previous Monday’s earnings.
The film significantly outpaced the 2009 entry’s second Monday total of $2.9 million and also topped fellow post-COVID horror sequels like A Quiet Place Part II ($2.3M), NOPE ($2.5M), and Beetlejuice Beetlejuice ($3M). The only post-pandemic horror release to surpass it is Ryan Coogler’s Sinners, with $5.5M. Bloodlines now ranks as the second-highest second Monday gross for an R-rated horror film since COVID.
Marching Toward $100 Million Milestone
With this strong momentum, the film’s domestic total has reached $94.3 million, and it’s expected to cross the $100 million mark by Thursday or Friday. Industry experts project a final run between $125 million and $135 million, positioning it as one of the most commercially successful entries in the Final Destination series.
Also Read: Final Destination Bloodlines Dialogues : It’s time for another Spine-Chilling Tale of Survival
A Reimagined Horror Legacy
Directed by Zach Lipovsky and Adam Stein and written by Guy Busick and Lori Evans Taylor, Final Destination: Bloodlines marks the sixth installment in the long-running horror saga. It stars Kaitlyn Santa Juana as a college student plagued by deadly premonitions inherited from her grandmother. These visions connect to a near-disaster in 1968 and hint that death is circling back for revenge.
The cast includes Teo Briones, Richard Harmon, Brec Bassinger, and horror legend Tony Todd in his final screen appearance. Originally slated for a streaming debut, Warner Bros. pivoted to a theatrical release in March 2024, and the gamble has clearly paid off.
